Sanjeev Mariathasan

USPTO Granted Patents = 16 (Patent Applications = 26)

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 8.5

ph-index = 5

Forward Citations = 451(Granted Patents)

Location History:

Millbrae, CA (US) (2012 - 2020)
South San Francisco, CA (US) (2022)

Company Filing History:

Aimm Therapeutics B.v.

patents

2 out of 39

Foundation Medicine, Inc.

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12331128 - Therapeutic and diagnostic methods for cancer (2025-06-17),

2. 11535671 - Therapeutic and diagnostic methods for cancer (2022-12-27),

3. 11279767 - Therapeutic and diagnostic methods for cancer (2022-03-22),

4. 10570192 - Anti-wall teichoic antibodies and conjugates (2020-02-25),

5. 9927428 - Gram-positive bacteria specific binding compounds (2018-03-27),

6. 9920123 - Anti-PD-L1 antibodies, compositions and articles of manufacture (2018-03-20),

7. 9895450 - Anti-wall teichoic antibodies and conjugates (2018-02-20),

8. 9884126 - Anti-wall teichoic antibodies and conjugates (2018-02-06),

9. 9803002 - Anti-wall teichoic antibodies and conjugates (2017-10-31),

10. 9688745 - Gram-positive bacteria specific binding compounds (2017-06-27),

11. 9458228 - Gram-positive bacteria specific binding compounds (2016-10-04),

12. 9399673 - Gram-positive bacteria specific binding compounds (2016-07-26),

13. 9266943 - Gram-positive bacteria specific binding compounds (2016-02-23),

14. 9090677 - Gram-positive bacteria specific binding compounds (2015-07-28),

15. 8617556 - Gram-positive bacteria specific binding compounds (2013-12-31),

Title: The Innovative Journey of Sanjeev Mariathasan

Introduction

Sanjeev Mariathasan, based in Millbrae, California, is a prominent inventor known for his substantial contributions to cancer research and diagnostics. With an impressive portfolio of 15 patents, Sanjeev is dedicated to enhancing therapeutic methods and diagnostic processes specifically for bladder cancer.

Latest Patents

Among his latest innovations, Sanjeev has developed therapeutics and diagnostic methods aimed at tackling cancer. His inventions focus on bladder cancer, offering methods that determine a patient’s likelihood of responding to treatments involving PD-L1 axis binding antagonists. These patents include methods for selecting therapies based on the expression levels of specific biomarkers and somatic mutation levels found in tumor samples. His work significantly advances the possibilities for personalized medicine in cancer treatment.

Career Highlights

Sanjeev has made notable strides in his career, having worked with prestigious companies such as Genentech, Inc. and Aimm Therapeutics B.V. His experience in these leading research institutions has allowed him to apply his innovative ideas to real-world applications, thus facilitating progress in cancer therapies.

Collaborations

Throughout his career, Sanjeev has collaborated with esteemed colleagues, including Eric J. Brown and John Hiroshi Morisaki. These relationships have fostered a dynamic environment for innovation, contributing to various projects aimed at revolutionizing medical treatment options.

Conclusion

Sanjeev Mariathasan stands as a visionary in the realm of cancer research and treatment. With a commitment to innovation reflected in his numerous patents, he continues to pave the way for advancements in diagnostics and therapies. His career serves as an inspiration for aspiring inventors and researchers in the medical field.

This text is generated by artificial intelligence and may not be accurate.